The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Congressionally Directed Medical Research Programs -- Ovarian Cancer Research Program -- Ovarian Cancer Academy Award -- Investigator-Initiated Research Award
The OCRP Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The application must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the application to be competitive. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project. These data may be unpublished or from the published literature.
If cell lines or animals are to be used, a clear justification should be provided for the choice of proposed cell line(s) or animal model(s).
• Required Pre-Application Deadline: May 2, 2022
• Invitation to Submit an Application: June 2022
• Application Submission Deadline: Aug. 5, 2022
Areas of Interest
To be considered for funding, applications for the FY22 OCRP Investigator-Initiated Research Award must address a critical component of at least one of the Areas of Emphasis listed below, unless adequate justification for exception is provided.* • Understand the basic biology and etiology of ovarian cancer initiation, progression, metastasis, recurrence, genetics and other critical events • Develop novel therapeutic strategies for treatment and prevention • Identify and develop new strategies for screening, early-stage detection, prevention, accurate diagnosis and prognosis • Identify and implement strategies to improve OCRP’s survivorship and quality of life • Address health disparities • Improve precision medicine
An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by or affiliated with an eligible organization.
The anticipated direct costs budgeted for the entire period of performance for an FY22 Investigator-Initiated Research Award will not exceed $600,000 with a single PI or $800,000 with a partnering PI. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.